CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes

Relapse is the main cause of treatment failure after allogeneic stem cell transplant (alloSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Injectable azacitidine can improve post-transplant outcomes but presents challenges with exposure and compliance. Oral CC-486 allows ext...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biol Blood Marrow Transplant
Auteurs principaux: de Lima, Marcos, Oran, Betul, Champlin, Richard E., Papadopoulos, Esperanza B., Giralt, Sergio A., Scott, Bart L., William, Basem M., Hetzer, Joel, Laille, Eric, Hubbell, Becky, Skikne, Barry S., Craddock, Charles
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8059405/
https://ncbi.nlm.nih.gov/pubmed/29933073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.06.016
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires